[1]
2021. Umbilical Cord Tissue-derived Mesenchymal Stem Cells Should be Considered as Adjuvant Therapy for COVID-19 Treatment: An Opinion from Pooled Clinical Evidence. Biomedical Research and Therapy. 8, 9 (Sep. 2021), 4583–4595. DOI:https://doi.org/10.15419/bmrat.v8i9.694.